Massachusetts § 17R Coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome

Massachusetts Statutes

§ 17R — Coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome

Massachusetts § 17R

Part IADMINISTRATION OF THE GOVERNMENT

Title IVCIVIL SERVICE, RETIREMENTS AND PENSIONS

Ch. 32ACONTRIBUTORY GROUP GENERAL OR BLANKET INSURANCE FOR PERSONS IN THE SERVICE OF THE COMMONWEALTH

This text of Massachusetts § 17R (Coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome) is published on Counsel Stack Legal Research, covering Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Mass. Gen. Laws ch. 32A, § 17R (2026).

Text

[Text of section effective as applied to contracts that take effect or are renewed on or after January 1, 2022. See 2020, 260, Sec. 74.]

Section 17R. The commission shall provide to any active or retired employee of the commonwealth who is insured under the group insurance commission coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome, including, but not limited to, the use of intravenous immunoglobulin therapy.

Free access — add to your briefcase to read the full text and ask questions with AI

[Text of section effective as applied to contracts that take effect or are renewed on or after January 1, 2022. See 2020, 260, Sec. 74.]

Section 17R. The commission shall provide to any active or retired employee of the commonwealth who is insured under the group insurance commission coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome, including, but not limited to, the use of intravenous immunoglobulin therapy.